Product Description: (R)-Elsubrutinib ((R)-ABBV-105) is a Btk inhibitor. (R)-Elsubrutinib can be used in studies of immune diseases (such as rheumatoid arthritis, psoriasis, ankylosing spondylitis, asthma, systemic lupus erythematosus) and cancer[1].
Applications: COVID-19-immunoregulation
Formula: C17H19N3O2
References: [1]Dominique Bonafoux, et al. Primary carboxamides as Btk inhibitors. Patent WO2014210255Al.
CAS Number: 1643570-23-3
Molecular Weight: 297.35
Compound Purity: 98.0
Research Area: Cancer; Inflammation/Immunology
Solubility: DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)
Target: Btk